Loading…
Sectoral / Thematic · DSP Mutual Fund · AMFI code 145453DSP Healthcare Fund
Disclosed for 94 months, Dec 2018 to Sep 2026.
Portfolio value
₹1,087 Cr
up ₹38.1 Cr vs Jan 2021
- Stocks held
- 24
- unchanged
- Top 10 weight
- 61.0%
- of the portfolio in its ten largest
- Cash & debt
- 5.5%
- cash, money market and debt
- Moves this month
- 0 in · 0 out
- added to 9, trimmed 13
DSP Healthcare Fund is an active equity fund in the Sectoral / Thematic category from DSP Mutual Fund. In February 2021 it disclosed 24 stocks worth ₹1,087 Cr, up ₹38.1 Cr from Jan 2021. Its largest positions were Cipla Limited (8.5%), Lupin Limited (7.8%), Sun Pharmaceutical Industries Limited (7.0%); the ten largest together made up 61.0% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 63.9% of its equity. Cash and debt stood at 5.5%. Compared with Jan 2021 the fund entered 0 new stocks and exited 0.
Against 229 other Sectoral / Thematic funds
Concentration
84%
Top-10 weight is higher than 84% of peers
Breadth
7%
Holds more stocks than 7% of peers
Cash
75%
Holds more cash than 75% of peers
What these mean: concentration · cash
Holdings in February 2021
Download CSVEvery line the fund disclosed, with the change against Jan 2021. Click a column to sort; click a company to see every fund that owns it. New to these? How to read a portfolio.
| Cipla Limited | 8.55% | down 0.75 pts | ₹92.9 Cr | down ₹4.6 Cr | Trimmed |
| Lupin Limited | 7.83% | down 0.20 pts | ₹85.1 Cr | up ₹90 L | Added |
| Sun Pharmaceutical Industries Limited | 6.96% | down 0.15 pts | ₹75.7 Cr | up ₹1.1 Cr | Added |
| Dr. Reddy's Laboratories Limited | 6.82% | down 0.53 pts | ₹74.1 Cr | down ₹2.9 Cr | Trimmed |
| IPCA Laboratories Limited | 6.72% | down 0.25 pts | ₹73 Cr | down ₹10 L | Held |
| Apollo Hospitals Enterprise Limited | 5.92% | up 0.78 pts | ₹64.4 Cr | up ₹10.5 Cr | Added |
| Cash, TREPS & receivables | 5.49% | up 3.07 pts | ₹59.7 Cr | up ₹34.3 Cr | Added |
| Procter & Gamble Health Limited | 5.25% | down 0.53 pts | ₹57.1 Cr | down ₹3.5 Cr | Trimmed |
| Divi's Laboratories Limited | 5.20% | down 0.20 pts | ₹56.5 Cr | down ₹11 L | Held |
| Max Healthcare Institute Limited | 4.45% | up 0.32 pts | ₹48.4 Cr | up ₹5.1 Cr | Added |
| JB Chemicals & Pharmaceuticals Limited | 3.25% | up 0.24 pts | ₹35.3 Cr | up ₹3.7 Cr | Added |
| Torrent Pharmaceuticals Limited | 3.17% | down 0.36 pts | ₹34.4 Cr | down ₹2.6 Cr | Trimmed |
| ICICI Lombard General Insurance Company Limited | 3.17% | up 0.14 pts | ₹34.4 Cr | up ₹2.7 Cr | Added |
| Intuitive Surgical Inc | 3.10% | down 0.16 pts | ₹33.7 Cr | down ₹45 L | Trimmed |
| Abiomed Inc | 2.92% | down 0.32 pts | ₹31.8 Cr | down ₹2.3 Cr | Trimmed |
| Dr. Lal Path Labs Limited | 2.73% | down 0.03 pts | ₹29.7 Cr | up ₹69 L | Added |
| Narayana Hrudayalaya Limited | 2.61% | down 0.18 pts | ₹28.4 Cr | down ₹94 L | Trimmed |
| Abbott Laboratories | 2.54% | down 0.17 pts | ₹27.6 Cr | down ₹84 L | Trimmed |
| Syngene International Limited | 2.39% | down 0.12 pts | ₹26 Cr | down ₹34 L | Trimmed |
| Indoco Remedies Limited | 2.22% | down 0.16 pts | ₹24.1 Cr | down ₹80 L | Trimmed |
| Alkem Laboratories Limited | 2.18% | down 0.32 pts | ₹23.7 Cr | down ₹2.5 Cr | Trimmed |
| Unichem Laboratories Limited | 2.02% | up 0.22 pts | ₹22 Cr | up ₹3.1 Cr | Added |
| Alembic Pharmaceuticals Limited | 1.89% | down 0.14 pts | ₹20.5 Cr | down ₹71 L | Trimmed |
| Aarti Drugs Limited | 1.77% | down 0.19 pts | ₹19.3 Cr | down ₹1.3 Cr | Trimmed |
| Abbott India Limited | 0.84% | down 0.02 pts | ₹9.1 Cr | up ₹11 L | Added |
What changed, Jan 2021 to Feb 2021
New New positions (0)
None.
Exited Exited (0)
None.
Added Biggest additions
- Apollo Hospitals Enterprise Limitedup ₹10.5 Cr (+0.78% pts)
- Max Healthcare Institute Limitedup ₹5.1 Cr (+0.32% pts)
- JB Chemicals & Pharmaceuticals Limitedup ₹3.7 Cr (+0.24% pts)
- Unichem Laboratories Limitedup ₹3.1 Cr (+0.22% pts)
- ICICI Lombard General Insurance Company Limited
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since Jan 2021, the weight rose most in Healthcare Services (+1.2 pts) and Insurance (+0.2 pts), and fell most in Pharmaceuticals & Biotechnology (−1.5 pts).
- Healthcare Services21.1% → 22.3%+1.2 pts
- Insurance3.1% → 3.4%+0.2 pts
- Pharmaceuticals7.1% → 7.2%+0.1 pts
- Pharmaceuticals & Biotechnology65.4% → 63.9%−1.5 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | Feb 2020 | Aug 2020 | Nov 2020 | Jan 2021 | Feb 2021 |
|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 66.5% | 64.7% | 63.0% | 65.4% | 63.9% |
| Healthcare Services | 21.1% | 19.9% | 21.9% | 21.1% | 22.3% |
| Pharmaceuticals | 11.2% | 9.0% | 7.3% | 7.1% | 7.2% |
| Insurance | 1.2% | 2.7% | 4.0% | 3.1% | 3.4% |
| Healthcare Equipment & Supplies | — | 3.6% | 3.8% | 3.3% | 3.3% |
Allocation in Feb 2021change vs Jan 2021
- Pharmaceuticals & Biotechnology (13)63.9%▼ 1.5 pts
- Healthcare Services (6)22.3%▲ 1.2 pts
- Pharmaceuticals (3)7.2%▲ 0.1 pts
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal. More on reading cash.
Cash & debt, Feb 2021
5.5%
▲ 3.1 pts vs Jan 2021
- Cash alone
- 5.5%
- cash and net receivables
- A year earlier
- 5.3%
- Feb 2020 · now ▲ 0.2 pts
- Last 12 months
- 1.8% – 8.5%
- lowest to highest · record 28.6% in Dec 2018
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.